BNTX: BioNTech SE
Performance
BNTX -15.15%
Watchlist
Select an item
Summary
BNTX at a glance
BNTX returned -15.15% over the past year and -16.32% a year over five years. Its worst drop in that year was -29.70%, smaller than 58% of stocks on Redstone, and its Sharpe ratio of -0.19 beats 19% of stocks on Redstone. It pays no dividends.
Current Drawdown
-26.67%
Rolling Volatility
39.59%
Actions
Metrics
Risk Indicators
Alpha-19.14%
Beta1.02x
Sharpe-0.19
Sortino-0.28
Omega0.96
Calmar-0.51
Martin-0.48
Profile
About BNTX
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid.
- Sector
- Health Care
- Market cap
- $21.7B
- Listed
- Oct 2019
- Employees
- 7,807
- Website
- biontech.de
Comparisons